Type 2 diabetes in children and adolescents: Exploring the disease heterogeneity and research gaps to optimum management

doi:10.5409/wjcp.v13.i2.91587

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (573)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

HTML

323

Figures (1-2)

Tables (1-2)

Sum=480

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=63

Jun 9, 2024 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Pediatr. Jun 9, 2024; 13(2): 91587
Published online Jun 9, 2024. doi: 10.5409/wjcp.v13.i2.91587

Open in New Tab Full Size Figure Download Figure

Figure 1 Approach to etiological diagnosis of diabetes in adolescents. LADY: Latent autoimmune diabetes in young; MODY: Maturity onset diabetes in young; MPD: Main pancreatic duct; OHA: Oral hypoglycemic agent; SU: Sulfonylurea; USG: Ultrasonography.

Open in New Tab Full Size Figure Download Figure

Figure 2 Approach to treatment of type 2 diabetes in children and adolescents. Modified from Karavanaki et al[104].

Citation: Pramanik S, Mondal S, Palui R, Ray S. Type 2 diabetes in children and adolescents: Exploring the disease heterogeneity and research gaps to optimum management. World J Clin Pediatr 2024; 13(2): 91587
URL: https://www.wjgnet.com/2219-2808/full/v13/i2/91587.htm
DOI: https://dx.doi.org/10.5409/wjcp.v13.i2.91587